Next Generation Stent Technologies

Overtaking Traditionally Dominant Bare-Metal Stents (BMS), Drug-eluting (DES) and Bioabsorbable Stents Race Ahead

USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

The coronary stent market is in the midst of tremendous change. The declining popularity of bare-metal stents have opened up opportunities for the next generation of stents to occupy the market share. This research service identifies possible areas of innovation available for stent companies to leverage and differentiate their products in a highly competitive market. This research service will act as a guide for medical device, materials, pharmaceuticals and contract manufacturers looking for possible opportunities in the stent market.

Table of Contents

1.0 Executive Summary1.1 What You Can Expect1.2 Research Methodology1.2 Research Methodology (continued)1.3 Ageing Population, Unhealthy Lifestyles Are Key Drivers for Coronary Stents Adoption2.0 Overview of Stent Industry2.1 The Growing Importance of Coronary Stents2.2 A Snapshot of Stent Applications2.3 Stent Design: A Generational Change2.4 A Snapshot of Stent Technology and Product Design 2.5 Stent Design: Technology Evolution2.6 Changing Trends of Coronary Stents Market2.7 Declining Market Share of BMS Provides Opportunities for DES, BAS2.8 Snapshot of Prominent Stent Players2.9 Drug-eluting Stents: Common Pain Points2.10 Drug-eluting Stents: Needs Assessment3.0 Technology Trends and Analysis3.1 Areas of Innovation: Stent Attributes That Can Be Mined for Product Design Innovations3.2 Stent Platform: Identifying Key Design Considerations3.2.1 A Summary of Commonly-used Stent Materials3.2.2 Cell Design, Stent Architecture Determine Stent Performance3.2.3 Assessing the Risks and Benefits of Strut Thickness3.3 Pharmaceutical Agents: Key Component in Fighting Restenosis3.3.1 Limus Drugs Dominate the DES Landscape3.3.2 DES Experiments with Cells, Proteins and Biologics 3.4 Stent Coatings: Imparting Bioactivity, Superior Functionality to Stents 3.4.1 The Future of Stent Design Lies with Stent Coatings3.4.1 The Future of Stent Design Lies with Stent Coatings (continued)4.0 Industry Trends and Analysis4.1 An Assessment of Key Growth Drivers and Challenges4.2 Limitations of BMS Lead Demand for DES, Innovations in Stent Design4.3 High Regulatory Barriers, Over-use of DES Are Main Challenges to Adoption4.4 Competition, Internal Threats Will Propel Innovation4.5 3D Printing, Surface Functionalization Will Lead Innovations in Stent Design5.0 Intellectual Property Landscape Analysis5.1 Patent Landscape Analysis5.2 Patent Landscape Analysis5.3 List of Recent Patents5.3 List of Recent Patents (continued)5.3 List of Recent Patents (continued)6.0 Database of Key Industry Participants6.1 Database of Key Industry ParticipantsLegal Disclaimer7.0 The Frost & Sullivan Story7.1 The Frost & Sullivan Story7.2 Value Proposition: Future of Your Company & Career7.3 Global Perspective7.4 Industry Convergence7.5 360º Research Perspective7.6 Implementation Excellence7.7 Our Blue Ocean Strategy

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.